| Smiles |
O7(C(OC(C6(C5(C(C4(C(C3(C(C(C(OC1(OC(C(O)C(C1OC2(OC(C(O)C(C2O)O)CO))O)CO))C(C3)O)(C)C)CC4)(C))CC5O)(C))(C)CC6)))(CCC=C(C)C)C)C(O)C(O)C(C7COC8(OC(C(O)C(C8O)O)C))O)
|
| CAS number |
94705-68-7
|
| Polar Surface Area |
377,29
|
| calculated LogS |
-4,812
|
| Molweight |
1109,3
|
| calculated LogP |
-0,6302
|
| H-Acceptors |
23
|
| H-Donors |
15
|
| Ro5 violations |
3
|
| Druglikeness |
-6,0966
|
| DrugScore |
0,1935746
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,2676
|
| Rat Acute Toxicity |
4,0254
|
| Acute Oral Toxicity |
I
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
-0,5964
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Inhibitor
|
| P-glycoprotein Inhibitor2 |
Non-inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,9263
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB+
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
High HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA+
|
| Structure |
94705-68-7
|
